Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$9.22 - $15.02 $714,550 - $1.16 Million
77,500 Added 242.98%
109,396 $1.15 Million
Q4 2023

Feb 13, 2024

BUY
$6.5 - $12.85 $207,324 - $409,863
31,896 New
31,896 $383,000
Q2 2023

Aug 14, 2023

BUY
$10.52 - $16.06 $762,089 - $1.16 Million
72,442 New
72,442 $975,000
Q1 2022

May 13, 2022

SELL
$12.92 - $27.18 $153,903 - $323,768
-11,912 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$21.96 - $42.69 $910,110 - $1.77 Million
-41,444 Reduced 77.67%
11,912 $314,000
Q3 2021

Nov 15, 2021

SELL
$41.3 - $54.56 $668,894 - $883,653
-16,196 Reduced 23.29%
53,356 $2.25 Million
Q2 2021

Aug 16, 2021

BUY
$38.61 - $55.0 $2,084 - $2,970
54 Added 0.08%
69,552 $3.78 Million
Q1 2021

May 14, 2021

BUY
$38.1 - $59.09 $464,324 - $720,129
12,187 Added 21.26%
69,498 $3.15 Million
Q4 2020

Feb 02, 2021

BUY
$33.26 - $59.72 $1.91 Million - $3.42 Million
57,311 New
57,311 $2.49 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $496M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.